Leading integrated radiotherapy systems maker Varian Medical (VAR) has secured the approval of the U.S. Food and Drug Administration (FDA) for its novel Proton Therapy System, which delivers protons ...
PALO ALTO, Calif., May 9, 2019 /PRNewswire/ -- Following a comprehensive evaluation by Sykehusbygg HF Norway and regional health authorities, Varian (NYSE: VAR) was selected to equip two proton ...
PALO ALTO, Calif. and JINAN, China, May 9, 2019 /PRNewswire/ -- Varian VAR today announced it has signed a strategic cooperation framework agreement with Shandong Cancer Hospital in China, for proton ...
PALO ALTO, Calif., March 17, 2020 /PRNewswire/ -- Varian (NYSE: VAR) announced today, Proton International at UAB has now treated its first cancer patient with the Varian ProBeam ® Compact proton ...
Flash ultra-high dose rate therapy enabled by Varian proton and planning technologies Collaboration between Varian and leading institutions drives progress toward next-generation cancer treatments ...
The "United States Proton Therapy Market Report Forecast by Indication. States and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Proton Therapy ...
LITTLETON, Mass. & MORRISTOWN, N.J.--(BUSINESS WIRE)--Atlantic Health System, an integrated health care system setting standards for quality health care in New Jersey, Pennsylvania and the New York ...
* Varian Medical Systems Inc - received orders to provide suites of software for national proton therapy centers now being constructed in denmark, u.k. * Varian Medical Systems - confirmed that varian ...
Located in Flint, Mich., the Karmanos Cancer Institute at McLaren Health Care’s Flint Medical Center uses an advanced proton therapy treatment approach to care for cancer patients. Once considered ...
BRUSSELS, Dec 5 (Reuters) - Belgian cancer therapy company Ion Beam Applications said late on Friday that a Swedish court had cancelled a contract for a proton therapy centre awarded to rival Varian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results